EUCOPE’s Life Science Lectures – Episode Four

14. Dec 2023 — Register here


Episode 4  –  14 December 2023 (15:00 – 15:40 CET)

Leveraging early advice opportunities in EU HTA

On the fourth episode, we discuss how best to navigate early advice opportunities with the new EU health technology assessment (HTA), which will be mandatory for all new oncology products and ATMPs from 12 January 2025.

EUCOPE experts will go over the opportunities for receiving joint scientific advice from EMA and HTA bodies in parallel in the interim period leading up to 2025, discuss the features and requirements of the procedure and strategic considerations for companies.

Webinar Agenda

Panel (30-min) + Q&A (10-min)

  • Marcus Droege, Senior Advisor, Market Access & Commercial
  • Axel Korth, Senior Legal & Regulatory Affairs Advisor
  • Matias Olsen, Senior Manager, Public Affairs & Policy

You can register here.


Back to the events overview